Excision of Atrial Myxomas is progressing from Median Sternotomy to
Background: Atrial myxomas are rare benign tumors; causing obstructive
or embolic complications, and even death, depending on their site and
size. Therefore, once diagnosed, it should be surgically resected
emergency. Atrial myxomas are present about 75% in left atrium (LA) and
about 15% in right atrium (RA). Early diagnosis is a challenge because
of nonspecific manifestations, and sometimes is asymptomatic and
discovered accidentally during TTE. Objective: Minimally invasive
cardiac surgery (MICS) has benefits include cosmetically, less pain,
shorter intensive care unit (ICU) and hospital stay. Methods: From Jan.
2011 to Sept. 2020, (20) patients (10 Sternotomy, 10 MI) underwent
surgery for isolated resection of atrial myxoma. We reported outcomes;
cardiopulmonary bypass time (CPB), cross-clamp time, conversion to
median ST, length of stay, complications (stroke, renal failure,
respiratory failure, reoperation, and infection),pain, patients
satisfaction, recurrence and survival. Mean follow-up time was 6 month.
Results: There is no significant difference in CPB or cross-clamp time
between groups. No MI cases required conversion to a median ST. Length
of stay is shorter in the MI group by 2.2 days (p = 0.045). There is no
difference in morbidity or mortality between groups. Conclusions: A
minimally invasive approach for atrial myxoma resection is safe,
feasible, and favored over sternotomy.